Envoy Medical, Inc. (COCH) Reports Q2 Loss, Tops Revenue Estimates
Envoy Medical, Inc. (COCH) delivered earnings and revenue surprises of -10.34% and +39.29%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?